Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
InxMed logo — company profile

InxMed

Founded 2018 11-50 employees Debt Financing Total: $205.00M Biotechnology, Life Sciences

General Information

Company Name InxMed
Founded Year 2018
Founders / Decision Makers
Team member
Employees 11-50
Industries Biotechnology, Life Sciences
Funding Stage Debt Financing
Social

BounceWatch is an independent company data service, not affiliated with InxMed. To contact InxMed, visit en.inxmed.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does InxMed compare?

A PDF of InxMed and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting InxMed soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About InxMed

InxMed is a clinical-stage biotech company founded in 2018, dedicated to developing advanced combination medicines in the Biotechnology and Life Sciences industries. The company's focus is to provide new treatment options for patients. Their innovations are deeply rooted in a thorough understanding of disease biology and pharmacology, making them patient-inspired. InxMed's strategy revolves around the creation of a translational platform with global expertise and efficient execution capabilities.

The company recently secured a $10.00M Debt Financing investment on 21 July 2022, with SPD Silicon Valley Bank (SSVB) as the sole investor.

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Debt Financing $10.00M 1
SPD Silicon Valley Bank (SSVB)
21 Jul 2022
Series B $15.00M 2
CBC Group Hyfinity Investments
CBC Group, Hyfinity Investments
08 May 2022
Series B $50.00M 5
AIHC Capital
AIHC Capital, Ennovation Ventures +3
03 Mar 2022
Series A CNY130.00M 2
China Growth Capital
China Growth Capital, Ennovation Ventures
04 Sep 2020

InxMed Alternatives & Competitors

View All Alternatives
InxMed vs
Synnovation Therapeutics
Synnovation Therapeutics United States

A precision oncology company focused on small molecule therapies optimized to target key driver mech...

Series A
52 employees
Biotechnology, Health Care
InxMed vs
Scorpion Therapeutics
Scorpion Therapeutics

Pioneering the Next Generation of Precision Oncology

Series C
16 employees
Biotechnology, Health Care
InxMed vs
Cognition Therapeutics, Inc.
Cognition Therapeutics, Inc. United States

Advancing Accessible Solutions for Complex Neurodegenerative Diseases

IPO
29 employees
Biotechnology, Health Care
View all alternatives

FAQ About InxMed

InxMed is a clinical-stage biotech company dedicated to developing advanced combination medicines to provide new treatment options for patients. Our innovations are patient-inspired and driven by a deep understanding of disease biology and pharmacology. InxMed is focused on building a translational...
InxMed was founded in 2018.
InxMed operates in Biotechnology and Life Sciences.
InxMed has approximately 11-50 employees.
InxMed has completed 4 funding rounds, raising a total of $205.00M. The latest funding stage is Debt Financing.
Top alternatives and competitors to InxMed include Synnovation Therapeutics, Scorpion Therapeutics, Cognition Therapeutics, Inc., Rubedo Life Sciences, Eikon Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
InxMed and Synnovation Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for InxMed, https://bouncewatch.com/company/inxmed, updated 27 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes